15/11/2024  17:00:12 Var. +0.60 Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
29.50EUR +2.08% 58
Fatturato: 1,726.15
-Quantità in denaro: - -Quantità in lettera: - 353.74 mill.EUR 1.89% 27.20

Descrizione business

STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Marcus Wolfinger
Consiglio di amministrazione
Dr. Claus Vielsack, Dr. Robert Siegle, Dr. Georg Bauer
Consiglio di sorveglianza
Prof. Dr. Georg Heni, Dr. Frank Hiller, Dr. Rolf Vornhagen, Dr. Patricia Geller
 

Dati aziendali

Name: STRATEC SE
Indirizzo: Gewerbestraße 37,D-75217 Birkenfeld
Telefono: +49-7082-7916-0
Fax: +49-7082-7916-999
E-mail: info@stratec.com
Internet: www.stratec.com
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 35.57%
Data dell'IPO: 25/08/1998

Rapporti con gli investitori

Name: Jan Keppeler
IR telefono: +49-7082-7916-991
IR Fax: +49-7082-7916-9190
IR e-mail: ir@stratec.com

Principali azionisti

Altri
 
86.96%
Invesco Ltd.
 
5.01%
Brown Capital Management, LLC
 
5.01%
Juno Investment Partners B.V
 
3.02%